Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, supplying promising breakthroughs across a variety of health-related and industrial purposes. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, much more reliable different for therapeutic use